Some patients with large vessel occlusion strokes may still benefit from thrombolysis even after the traditional 4.5-hour window, new analysis of the TIMELESS trial suggested.
Late tenecteplase treatment (4.5-24 hours post-stroke) did not benefit patients with large-vessel occlusion stroke, but could help those with M1 occlusions, a new study showed.
The company’s roster of clinical evidence continues to grow, with data highlights on expediting, broadening, and challenging current guidelines in stroke care
RapidAI to Enter ISC 2024 Showcasing Extensive Research and Unparalleled Industry Leadership streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.